• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度东北部阿萨姆邦有报告风险因素人群中的丙型肝炎病毒基因型:基因型 8 的出现。

Hepatitis C virus genotypes among population with reported risk factors in Assam, north-east India: Emergence of genotype-8.

机构信息

Department of Microbiology, Gauhati Medical College and Hospital, Guwahati, India.

Department of Microbiology, Dhubri Medical College and Hospital, Dhubri, India.

出版信息

Indian J Med Res. 2024 Jul;160(1):43-50. doi: 10.25259/ijmr_1222_23.

DOI:10.25259/ijmr_1222_23
PMID:39382494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11463879/
Abstract

Background & objectives Hepatitis C virus (HCV) exhibits extensive genetic diversity in infected hosts. There are few published reports of HCV genotype (GT) distribution from the north-east Indian States lying close to the 'Golden Triangle' known for illicit drug trafficking. Real-time knowledge of HCVGT distribution is important for studies on epidemiologic aspects and virus evolution and for the development of new target-specific, direct-acting antiviral drugs. This study aims to examine the distribution of HCVGTs and their subtypes in different risk groups from Assam, north-east India. Methods It is a hospital-based cross-sectional study. Plasma samples reactive for anti-HCV antibody in enzyme-linked immunosorbent assay (ELISA) were subjected to viral load test and genotyping by real-time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) or characterization of non-structural protein NS5B region by nested PCR. Nucleotide sequences were subjected to phylogenetic analysis. Results The most common HCVGT detected was GT-3 (95.89%), followed by GT-1 (3.42%), GT-6xa (0.34%) and GT-8 (0.34%). The mean age of subjects was 30.24 yr, and males outnumbered females. The most commonly associated risk factor was injecting drug use (IDU) (74.31%), followed by tattooing and/or piercing (33.22%), transfusion of blood/blood products (10.27%), and haemodialysis (9.25%). Co-infection with human immunodeficiency virus (HIV) was found in 17.8 per cent, and with Hepatitis B virus (HBV) in 3.42 per cent of the cases. Interpretation & conclusions The detection of HCVGT-8 makes this the first report from Assam and the second from India as per the authors' knowledge. This may indicate strain's endemic nature in India. The increasing trend of HCV infection among young IDUs and HCV-HIV co-infection indicates the need for enhancing surveillance and intensified prevention efforts among young adults.

摘要

背景与目的

丙型肝炎病毒(HCV)在受感染的宿主中表现出广泛的遗传多样性。在靠近以非法贩毒而闻名的“金三角”的东北部印度邦,有关 HCV 基因型(GT)分布的报道很少。实时了解 HCVGT 分布情况对于研究流行病学方面和病毒进化以及开发新的针对特定靶点的直接作用抗病毒药物非常重要。本研究旨在检查来自印度东北部阿萨姆邦不同风险群体的 HCVGT 及其亚型的分布情况。

方法

这是一项基于医院的横断面研究。酶联免疫吸附试验(ELISA)中对 HCV 抗体呈反应性的血浆样本进行病毒载量检测和实时逆转录-聚合酶链反应(RT-PCR)基因分型,或通过巢式 PCR 对非结构蛋白 NS5B 区进行特征分析。核苷酸序列进行了系统发育分析。

结果

检测到的最常见 HCVGT 是 GT-3(95.89%),其次是 GT-1(3.42%)、GT-6xa(0.34%)和 GT-8(0.34%)。研究对象的平均年龄为 30.24 岁,男性多于女性。最常见的相关风险因素是注射吸毒(IDU)(74.31%),其次是纹身和/或穿孔(33.22%)、输血/血制品(10.27%)和血液透析(9.25%)。17.8%的病例合并感染人类免疫缺陷病毒(HIV),3.42%的病例合并感染乙型肝炎病毒(HBV)。

结论与解释

检测到 HCVGT-8 是首次从阿萨姆邦报道,也是据作者所知,第二次从印度报道。这可能表明该毒株在印度具有地方性。在年轻人 IDU 中 HCV 感染呈上升趋势,以及 HCV-HIV 合并感染表明需要加强对年轻人的监测和强化预防措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ed/11463879/85db0d3a07db/IJMR-160-1-43-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ed/11463879/22a1b1dcb527/IJMR-160-1-43-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ed/11463879/30d6a3239e2d/IJMR-160-1-43-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ed/11463879/85db0d3a07db/IJMR-160-1-43-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ed/11463879/22a1b1dcb527/IJMR-160-1-43-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ed/11463879/30d6a3239e2d/IJMR-160-1-43-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ed/11463879/85db0d3a07db/IJMR-160-1-43-g3.jpg

相似文献

1
Hepatitis C virus genotypes among population with reported risk factors in Assam, north-east India: Emergence of genotype-8.印度东北部阿萨姆邦有报告风险因素人群中的丙型肝炎病毒基因型:基因型 8 的出现。
Indian J Med Res. 2024 Jul;160(1):43-50. doi: 10.25259/ijmr_1222_23.
2
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
3
Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.中国注射吸毒者中丙型肝炎病毒感染的流行病学:系统评价与荟萃分析。
Public Health. 2008 Oct;122(10):990-1003. doi: 10.1016/j.puhe.2008.01.014. Epub 2008 May 19.
4
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
5
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.
6
Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.聚乙二醇干扰素 α 和利巴韦林治疗适合缩短疗程、再治疗或合并 HCV/HIV 感染的慢性丙型肝炎患者:系统评价和经济评估。
Health Technol Assess. 2011 Apr;15(17):i-xii, 1-210. doi: 10.3310/hta15170.
7
Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units.隔离作为血液透析单位控制丙型肝炎病毒(HCV)感染传播的一种策略。
Cochrane Database Syst Rev. 2016 Aug 11;2016(8):CD006420. doi: 10.1002/14651858.CD006420.pub2.
8
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.针具交换计划和阿片类药物替代疗法预防注射吸毒者丙型肝炎传播
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012021. doi: 10.1002/14651858.CD012021.pub2.
9
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.全球注射吸毒流行状况以及注射吸毒者的社会人口学特征和艾滋病毒、乙肝病毒及丙肝病毒流行状况:多阶段系统评价。
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23.
10
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.

引用本文的文献

1
The Genotypes/Subtypes and Antiviral Drug Resistance of the Hepatitis C Virus from Patients in a Tertiary Care Hospital in Nepal.尼泊尔一家三级护理医院中丙型肝炎病毒患者的基因型/亚型及抗病毒药物耐药性
Viruses. 2025 Mar 6;17(3):377. doi: 10.3390/v17030377.

本文引用的文献

1
HIV, hepatitis B & C in people who inject drugs in India: A systematic review of regional heterogeneity & overview of opioid substitution treatment.印度注射吸毒人群中的 HIV、乙型肝炎和丙型肝炎:区域异质性的系统评价及阿片类药物替代治疗概述。
Indian J Med Res. 2023 Nov 1;158(5&6):522-534. doi: 10.4103/ijmr.ijmr_1930_23. Epub 2024 Jan 24.
2
Systematic Review and Meta-Analysis of Global Prevalence of HBsAg and HIV and HCV Antibodies among People Who Inject Drugs and Female Sex Workers.注射吸毒者和女性性工作者中乙肝表面抗原、艾滋病毒和丙肝抗体全球流行率的系统评价与荟萃分析
Pathogens. 2020 May 31;9(6):432. doi: 10.3390/pathogens9060432.
3
Diversity of hepatitis C virus infection among HIV-infected people who inject drugs in India.
印度注射毒品的艾滋病毒感染者中丙型肝炎病毒感染的多样性。
Virusdisease. 2019 Dec;30(4):490-497. doi: 10.1007/s13337-019-00553-2. Epub 2019 Dec 7.
4
Identification of a New HCV Subtype 6xg Among Injection Drug Users in Kachin, Myanmar.在缅甸克钦邦注射吸毒者中鉴定出一种新型丙型肝炎病毒6xg亚型。
Front Microbiol. 2019 Apr 18;10:814. doi: 10.3389/fmicb.2019.00814. eCollection 2019.
5
Hepatitis C virus and its genotypes in chronic liver disease patients from Meghalaya, Northeast India.印度东北部梅加拉亚邦慢性肝病患者中的丙型肝炎病毒及其基因型
Indian J Med Microbiol. 2018 Jul-Sep;36(3):376-380. doi: 10.4103/ijmm.IJMM_17_371.
6
Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes.从印度旁遮普邦鉴定出一种新型丙型肝炎病毒:将丙型肝炎病毒分类扩展到 8 个基因型。
J Infect Dis. 2018 Oct 20;218(11):1722-1729. doi: 10.1093/infdis/jiy401.
7
MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms.MEGA X:跨越计算平台的分子进化遗传学分析。
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549. doi: 10.1093/molbev/msy096.
8
Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes.丙型肝炎病毒感染的全球流行病学:丙型肝炎病毒基因型分布与传播的最新情况
World J Gastroenterol. 2016 Sep 14;22(34):7824-40. doi: 10.3748/wjg.v22.i34.7824.
9
Hepatitis C virus (HCV) infection & risk factors for HCV positivity in injecting & non-injecting drug users attending a de-addiction centre in northern India.印度北部一家戒毒中心注射吸毒者和非注射吸毒者中的丙型肝炎病毒(HCV)感染及HCV阳性的危险因素
Indian J Med Res. 2015 Sep;142(3):311-6. doi: 10.4103/0971-5916.166596.
10
Hepatitis C virus genotype 7, a new genotype originating from central Africa.丙型肝炎病毒基因7型,一种源自中非的新型基因型。
J Clin Microbiol. 2015 Mar;53(3):967-72. doi: 10.1128/JCM.02831-14. Epub 2014 Dec 17.